Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off

Group 1 - The analyst has a beneficial long position in the shares of COYA through stock ownership, options, or other derivatives [2] - The article expresses the analyst's own opinions and is not influenced by compensation from any company mentioned [2] - There is no business relationship with any company whose stock is mentioned in the article [2] Group 2 - The financial sector is the primary focus, with interests in technology, biotech, pharmaceutical companies, banks, and shipping [1]